API announces proposal to merge with Sigma

Under the scheme, API shareholders would own approximately 63% of the combined entity with Sigma shareholders owning the remaining 37% Australian Pharmaceutical Industries Limited (API) has today lodged a substantial shareholder notice with the ASX to confirm it is now holding 12.95% of shares in Sigma Healthcare Limited (Sigma). API has also reconfirmed the terms